Evidence map›Paper›PMID 38951583›Full record

ArticleScientific reports2024

Allergies and risk of head and neck cancer: a case-control study.

Sepehr Fekrazad, Elham Mohebbi, Sepideh Mehravar, Mahsa Mortaja, Farzad Teymouri, Maryam Hadji, Hamideh Rashidian, Ahmad Naghibzadeh-Tahami, Nima Rezaei, Kazem Zendehdel and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sepehr Fekrazad *Department of General Surgery, Subdivision of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Elham Mohebbi *Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Sepideh MehravarCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Keshavarz Boulevard, Tehran, Iran.
Mahsa MortajaCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Keshavarz Boulevard, Tehran, Iran.
Farzad TeymouriCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Keshavarz Boulevard, Tehran, Iran.
Maryam HadjiHealth Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Hamideh RashidianCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Keshavarz Boulevard, Tehran, Iran.
Ahmad Naghibzadeh-TahamiSocial Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Nima RezaeiCenter for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Kazem ZendehdelCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Keshavarz Boulevard, Tehran, Iran.
Mohammad ShirkhodaDepartment of General Surgery, Subdivision of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. mshirkhoda@sina.tums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the relationship between allergies and cancer has been investigated extensively, the role of allergies in head and neck cancer (HNC) appears less consistent. It is unclear whether allergies can independently influence the risk of HNC in the presence of substantial environmental risk factors, including consumption of alcohol, betel quid, and cigarettes. This study aims to find this association. We examined the relationship between allergies and HNC risk in a hospital-based case-control study with 300 cases and 375 matched controls. Logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals, controlling for age, sex, tobacco smoking and opium usage history, alcohol consumption, and socioeconomic status. Our study showed a significant reduction in the risk of HNC associated with allergy symptoms after adjusting for confounders. The risk of HNC was greatly reduced among those with any type of allergy (OR 0.42, 95% CI 0.28, 0.65). The ORs were considerably reduced by 58-88% for different kinds of allergies. The risk of HNC reduction was higher in allergic women than in allergic men (71% vs. 49%). Allergies play an influential role in the risk of HNC development. Future studies investigating immune biomarkers, including cytokine profiles and genetic polymorphisms, are necessary to further delineate the relationship between allergies and HNC. Understanding the relationship between allergies and HNC may help to devise effective strategies to reduce and treat HNC.

Indexed as

Head and Neck NeoplasmsHypersensitivityAdultAgedCase-Control StudiesFemaleHumansMaleMiddle AgedOdds RatioRisk FactorsAllergyHead and neck cancersImmunologyOnco-allergy

Identifiers

PMID38951583
PMCPMC11217420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.